logo
ResearchBunny Logo
Abstract
This study investigated the development of Omicron variant-neutralizing antibodies after repeated vaccination with the ancestral SARS-CoV-2 BNT162b2 vaccine. Analysis of blood samples from 41 vaccinees revealed that combinatorial reactivity to Omicron and its receptor-binding domain (RBD) was achieved through somatic hypermutation (SHM) accumulation after the third dose. A limited number of BCR clonotypes contributed to this broadened specificity, suggesting a counterprotective mechanism against viral immune escape.
Publisher
Nature Communications
Published On
Apr 20, 2024
Authors
Seoryeong Park, Jaewon Choi, Yonghee Lee, Jinsung Noh, Namphil Kim, JinAh Lee, Geummi Cho, Sujeong Kim, Duck Kyun Yoo, Chang Kyung Kang, Pyeong Gyun Cho, Nam Joong Kim, Wan Beom Park, Seungtake Kim, Myoung-ong Oh, Sunghoon Kwon, Junho Chung
Tags
Omicron variant
neutralizing antibodies
BNT162b2 vaccine
somatic hypermutation
viral immune escape
vaccination
BCR clonotypes

Related Publications

Explore these studies to deepen your understanding of the subject.

A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection
Medicine and Health

A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection

L. M. Coria, J. M. Rodriguez, et al.

Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination
Medicine and Health

Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination

X. Chi, Y. Guo, et al.

Human antibodies to SARS-CoV-2 with a recurring YYDRXG motif retain binding and neutralization to variants of concern including Omicron
Medicine and Health

Human antibodies to SARS-CoV-2 with a recurring YYDRXG motif retain binding and neutralization to variants of concern including Omicron

H. Liu, C. I. Kaku, et al.

An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants
Medicine and Health

An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants

W. Tai, S. Feng, et al.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs—just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny